Abstract: The embodiments herein provide a method and process for storing and provisioning system catalogue(s) of metadata object relationships, from diverse and disparate physical data elements. The method comprises the steps of creating a logical enterprise data warehouse by assembling a plurality of nanomart storage structures; visually mashing up a plurality of interconnected data elements from the plurality of nanomart storage structures to produce a business analytics; and generating a neural metadata framework for providing a mathematical model to abstract and catalogue the plurality of data elements from the plurality of nanomart storage structures.

Abstract: A system, a computer readable storage medium including instructions, and a computer-implemented method of pre-fetching in a network, are provided. In an example embodiment, computer-implemented method of pre-fetching in a network comprises receiving a request from a user device for a first network-accessible data item in the plurality of network-accessible data items; transmitting the first network-accessible data item to the user device; identifying a second network-accessible data item in the plurality of network-accessible data items; and transmitting the second network-accessible data item to the user device, the second network-accessible data item being transmitted before receiving a request for the second network-accessible data item from the user device. Pre-fetch logic may be embedded in the first network-accessible data item.

Abstract: A contoured check valve disc features a pivot portion and a check valve portion. The check valve portion is attached to the pivot portion, and has two sides, a first side to respond to the fluid flow in a first direction and move the check valve portion away from a fluid opening to the one or more open positions depending on the fluid flow to allow the fluid to flow through the fluid opening, and a second and opposing side to respond to fluid flow in an opposite direction through the fluid opening and move the check valve portion towards the fluid opening to the closed position to seal the fluid opening and stop fluid flow.

Abstract: An integrated circuit includes a signal network and a phase detector circuit. The signal network includes an adjustable delay circuit. The adjustable delay circuit is coupled at an intersection in the signal network between branches of the signal network. The signal network generates a first signal at a first leaf node of the signal network in response to a second signal. The signal network generates a third signal at a second leaf node of the signal network in response to the second signal. The phase detector circuit compares phases of the first and third signals to generate a phase detection signal. The adjustable delay circuit adjusts a delay provided to the first signal relative to the second signal to reduce a skew between the first and third signals based on the phase detection signal indicating that the first and third signals have the skew.

Abstract: Embodiments allow a primary database system (“primary”) to automatically detect queries directed to the primary database that may be offloaded to a standby database system (“standby”), and then to automatically offload the offload-eligible queries to a standby. The primary identifies offload-eligible queries based on a record of up-to-date database objects within each standby that replicates the primary database. The record of up-to-date standby objects is updated based on heartbeat messages from each standby, and commit timestamps for transactions on the primary. Evaluation of whether a query is offload-eligible is triggered by one or more trigger conditions that include: inclusion of an offload optimizer hint in the query, an estimated run-time of the query, etc. Embodiments further allow an offloaded query over particular changed data in the primary database to access, on a standby database, uncommitted changes made to the particular data in the primary database.

Abstract: A device can receive virtual network function (VNF) data associated with multiple VNFs. The device can generate multiple configuration templates that are to be used by a network design tool that is capable of creating a design of a network for an organization. The device can receive, from a user device, object data associated with network design objects that have been added to or removed from the interface of the network design tool. The device can generate multiple VNF configuration files that allow two or more of the multiple VNFs to be supported by network devices associated with the organization. The device can perform actions associated with configuring two or more of the multiple VNFs onto the network devices to permit the network devices to utilize virtual resources while executing the two or more of the multiple VNFs.

Abstract: Confidential, secret data may be shared via one or more blockchains. Mortgage applications, medical records, financial records, and other electronic documents often contain social security numbers, names, addresses, account information, and other personal data. A secret sharing algorithm is applied to any secret data to generate shares. The shares may then be integrated or written to one or more blockchains for distribution.

Abstract: Authentication of electronic document is based on multiple digital signatures incorporated into a blockchain. Structured data, metadata, and instructions may be hashed to generate the multiple digital signatures for distribution via the blockchain. Any peer receiving the blockchain may then verify an authenticity of an electronic document based on any one or more of the multiple digital signatures incorporated into the blockchain.

Abstract: Disclosed herein are compositions having a lipophilic active agent and methods of their use.

Abstract: The present invention relates to nanoparticles. In particular, the present invention provides nanoparticles for clinical (e.g., targeted therapeutic), diagnostic (e.g., imaging), and research applications in the field of cardiology. For example, in some embodiments, the present invention provides a method of treating (e.g., ablating) cardiac tissue, comprising: a) contacting an animal with a nanoparticle comprising a matrix, a toxic (e.g., ablative) agent (e.g., sonosensitizer, chemotherapeutic agent (e.g., doxorubicin or cisplatin), or photosensitizer), and a cardiac targeting moiety; and b) administering an activator of the toxic agent (e.g., light, chemical (e.g., pharmaceutical agent) or ultrasound) to at least a portion of the cardiac tissue (e.g., heart) of the animal to activate the toxic agent.

Abstract: A system and a method for process transaction visibility of one or more steps in a process lifecycle. The method includes identifying a current status of one or more process transactions at a first step of a process lifecycle and determining a change in the status of the one or more process transactions at the first step based the complete of a milestone of the one or more process transaction at the first step. A one or more Key Performance Indicators (KPIs) information is calculated for the current status and the changed status of the one or more process transactions to generate a KPIs report. A unified view of the current status and changed status of the one or more process transactions is displayed on a digital dashboard.

Abstract: Systems, methods, and computer program products relating to anchoring a wireless device to a wireless controller. A type of a network device is identified based on data included in a network message received at a first wireless local area network (LAN) controller (WLC). It is determined, based on the identified type, that the network device should be anchored to a pre-determined anchor WLC. An anchor request message is transmitted from the first WLC to the pre-determined anchor WLC. A network traffic tunnel is established between the network device and the pre-determined anchor WLC such that network traffic from the network device can be controlled by the pre-determined anchor WLC.

Abstract: The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, intravenous, spray, parenteral, lozenge, solution, syrup, sachet, transdermal administration, or injection. Such compositions may be used to treatment of inflammation or its associated complications.

Abstract: The present invention provides a system and apparatus for monitoring physiological data, more particularly to a sensor patch and digital framework for generating a virtual representation of an individual's body using IS physiological data. A user of the present invention will be able to actively perform medical and qualitative assessments of their health and generate alerts for significant departures from baseline statistics.

Abstract: There is provided systems and methods for two-factor authentication through ultrasonic audio transmissions. A user may utilize a first device request to process a transaction electronically by providing an electronic payment using an online service provider. When utilizing the service provider, authentication for the user's payment instrument and/or the user's account with service provider may require two-factor authentication using a one-time password that is unknown to the user and generated for the specific authentication request. The password may be generated and sent to a second device registered for the user and/or their account. The second device may process an ultrasonic handshake request with the first device, and may respond to the first device with an ultrasonic communication including the password. The first device may then automatically enter the password to the two-factor authentication process.

Abstract: This invention related to 4-substituted phenylamine derivatives of the general formula (I), wherein R1 to R9 and A have the meanings as defined in description. The invention further relates to methods for their preparation and use of said compounds to fight undesired phytopathogenic microorganisms, and agents for said purpose, comprising said phenylamine derivatives, all according to the invention. This invention further relates to a method for fighting undesired phytopathogenic microorganisms by application of said 4-substituted phenylamine derivatives of general formula (I) to such undesired microorganisms and/or to their habitat, according to the invention.

Abstract: The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone Cmax to serum testosterone Cave of about 2.7 or less. In yet another embodiment, a method for providing a serum concentration of testosterone within a target serum testosterone concentration Cave range for a male subject is provided.

Abstract: An example includes monitoring a media stream for a break of the media stream, the media stream being received by a media client; detecting the break of the media stream, where detection of the break indicates that supplemental content is to be provided during the break; sending a request for supplemental content information to a supplemental content server; receiving the supplemental content information for the break from the supplemental content server, the supplemental content information being based on the location of the media client; streaming the supplemental content to the media client within a supplemental content stream; and sending a notification to the media client, the notification including information that enables the media client to access the supplemental content stream during the break of the media stream based on the notification.

Abstract: Embodiments of the present invention relate to a system and method for determining a capacity utilisation of at least one of a cluster [104] and a base station [102]. More particularly, the embodiments may disclose a method for determining the capacity utilisation by receiving at least one message from at least one user equipment [110], wherein the at least one user equipment [110] belongs to the at least one cluster [104] having at least one cluster identifier and the at least one message includes uplink data and downlink data of the at least one user equipment [110]; generating a capacity utilisation list for said at least one cluster [104]; updating the capacity utilisation list with the uplink data and the downlink data; and determining a capacity utilisation for at least one of the cluster [104] and the base station [102] based on the uplink data and the downlink data.